adenosine diphosphate has been researched along with deamino arginine vasopressin in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (22.73) | 18.7374 |
1990's | 8 (36.36) | 18.2507 |
2000's | 2 (9.09) | 29.6817 |
2010's | 5 (22.73) | 24.3611 |
2020's | 2 (9.09) | 2.80 |
Authors | Studies |
---|---|
Czernichow, P; Limal, JM; Mugner, E | 1 |
Carr, ME; Zekert, SL | 1 |
Disa, J; Rao, AK; Yang, X | 1 |
Abel, RF; Brodsky, I; Conroy, JD; Parker, J; Putatunda, B; Schwartz, AB; Soslau, G | 1 |
De Marco, L; Girolami, A; Ruggeri, ZM; Zimmerman, TS | 1 |
Mohri, H | 1 |
Osmani, AH; Scrutton, MC; Thomas, ME | 1 |
Porta, M | 1 |
Lachant, NA; Paglieroni, TG; Wun, T | 1 |
Cattaneo, M; Lombardi, R; Mannucci, PM; Zighetti, ML | 1 |
Aye, MT; Ganz, PR; Hashemi, S; Palmer, DS | 1 |
Barişta, I; Demiroğlu, H; Dündar, S; Gürsoy, M; Oymak, O | 1 |
Balduini, CL; Belletti, S; Gamba, G; Noris, P; Spedini, P | 1 |
Callan, MB; Giger, U | 1 |
Blazicek, H; Domanovits, H; Galehr, E; Jilma, B; Jilma-Stohlawetz, P; Mayr, F; Reiter, RA | 1 |
Dietrich, W; Hofstetter, C; Jámbor, C; Spannagl, M; Weber, CF | 1 |
Dellweg, C; Görlinger, K; Hanke, AA; Kienbaum, P; Rahe-Meyer, N; Weber, CF | 1 |
Gneuss, A; Jürgens, T; Knöfler, R; Lohse, JE; Tauer, JT | 1 |
Brunner, K; Ehrenschwender, M; Kobsar, A; Koessler, J | 1 |
Cheung, CW; Lee, Y; Leung, SW; Ng, KF; Tsui, PY | 1 |
Brostjan, C; Buchtele, N; Derhaschnig, U; Gelbenegger, G; Gilbert, JC; Jilma, B; Kovacevic, KD; Schoergenhofer, C; Zhu, S | 1 |
Birschmann, I; Brandenburger, C; Budde, U; Dittrich, M; Flieder, T; Knabbe, C; Koster, A; Laser, KT; Sandica, E; Wolf, J | 1 |
3 trial(s) available for adenosine diphosphate and deamino arginine vasopressin
Article | Year |
---|---|
Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin.
Topics: Abciximab; Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Collagen; Cross-Over Studies; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Male; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2003 |
A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Arachidonic Acid; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Deamino Arginine Vasopressin; Drug Monitoring; Feasibility Studies; Female; Hemostatics; Humans; Male; Peptide Fragments; Platelet Aggregation; Point-of-Care Systems; Postoperative Hemorrhage; Predictive Value of Tests; Prospective Studies; Time Factors; Treatment Outcome | 2010 |
The effectiveness of low-dose desmopressin in improving hypothermia-induced impairment of primary haemostasis under influence of aspirin - a randomized controlled trial.
Topics: Adenosine Diphosphate; Aspirin; Collagen; Deamino Arginine Vasopressin; Double-Blind Method; Epinephrine; Female; Follow-Up Studies; Hemostasis; Hemostatics; Humans; Hypothermia; Male; Platelet Function Tests | 2015 |
19 other study(ies) available for adenosine diphosphate and deamino arginine vasopressin
Article | Year |
---|---|
[Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
Topics: Adenosine Diphosphate; Adolescent; Adult; Child; Child, Preschool; Deamino Arginine Vasopressin; Diabetes Insipidus; Diuresis; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infant; Lypressin; Male; Vasopressins | 1977 |
Force monitoring of clot retraction during DDAVP therapy for the qualitative platelet disorder of uraemia: report of a case.
Topics: Adenosine Diphosphate; Adult; Bleeding Time; Blood Platelet Disorders; Clot Retraction; Collagen; Deamino Arginine Vasopressin; Humans; Male; Platelet Aggregation; Uremia | 1991 |
Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
Topics: Adenosine Diphosphate; Arginine Vasopressin; Blood Platelets; Calcium; Deamino Arginine Vasopressin; Humans; In Vitro Techniques; Platelet Aggregation; Serotonin; Thrombin | 1990 |
Desmopressin-induced improvement in bleeding times in chronic renal failure patients correlates with platelet serotonin uptake and ATP release.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Aged; Bleeding Time; Blood Platelets; Deamino Arginine Vasopressin; Female; Hemostasis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Serotonin | 1990 |
von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
Topics: Adenosine Diphosphate; Afibrinogenemia; Bleeding Time; Blood Platelets; Collagen; Deamino Arginine Vasopressin; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation; Platelet Membrane Glycoproteins; Receptors, Cell Surface; von Willebrand Factor | 1986 |
Acquired von Willebrand disease in patients with polycythemia rubra vera.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aged; Antigens; Deamino Arginine Vasopressin; Factor VIII; Humans; Middle Aged; Platelet Aggregation; Polycythemia Vera; von Willebrand Diseases; von Willebrand Factor | 1987 |
Some properties of the human platelet vasopressin receptor.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Arginine Vasopressin; Calcimycin; Deamino Arginine Vasopressin; Humans; Oxytocin; Platelet Aggregation; Receptors, Cell Surface; Receptors, Vasopressin; Vasopressins | 1983 |
Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
Topics: Adenosine Diphosphate; Adult; Antigens; Arginine Vasopressin; Aspirin; Blood Coagulation Factors; Deamino Arginine Vasopressin; Diabetes Mellitus; Endothelium; Factor VIII; Humans; Male; Platelet Adhesiveness; Platelet Aggregation; von Willebrand Factor | 1982 |
Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Antidiuretic Hormone Receptor Antagonists; Antigens, CD; Arginine Vasopressin; Blood Platelets; Deamino Arginine Vasopressin; Dioxolanes; Dose-Response Relationship, Drug; Flow Cytometry; Hemostasis; Humans; In Vitro Techniques; P-Selectin | 1995 |
Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP.
Topics: Adenosine Diphosphate; Bleeding Time; Blood Platelet Disorders; Blood Platelets; Cells, Cultured; Deamino Arginine Vasopressin; Humans; Platelet Aggregation; Stress, Mechanical; von Willebrand Factor | 1994 |
Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Cells, Cultured; Cytokines; Deamino Arginine Vasopressin; Dioxolanes; Endothelium, Vascular; Epoprostenol; Humans; Kinetics; Monocytes; Platelet Activating Factor; Prostaglandins; von Willebrand Factor | 1993 |
The effect of desmopressin on platelet aggregation defect in systemic amyloidosis: a preliminary report.
Topics: Adenosine Diphosphate; Adolescent; Adult; Amyloidosis; Collagen; Deamino Arginine Vasopressin; Epinephrine; Familial Mediterranean Fever; Female; Humans; In Vitro Techniques; Male; Platelet Aggregation; Reference Values | 1996 |
In vitro and in vivo effects of desmopressin on platelet function.
Topics: Adenosine Diphosphate; Antigens, CD; Bleeding Time; Blood Platelets; Collagen; Deamino Arginine Vasopressin; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation | 1999 |
Effect of desmopressin acetate administration on primary hemostasis in Doberman Pinschers with type-1 von Willebrand disease as assessed by a point-of-care instrument.
Topics: Adenosine Diphosphate; Animals; Bleeding Time; Deamino Arginine Vasopressin; Dog Diseases; Dogs; Epinephrine; Female; Hemostasis; Hemostatics; Male; Platelet Aggregation; Platelet Count; von Willebrand Diseases | 2002 |
Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry*.
Topics: Acidosis; Adenosine Diphosphate; Adult; Blood Platelets; Cells, Cultured; Deamino Arginine Vasopressin; Female; Hemostatics; Humans; Hydrogen-Ion Concentration; Hypothermia; Male; Platelet Activation; Platelet Aggregation; Young Adult | 2010 |
Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adolescent; Aspirin; Blood Platelet Disorders; Blood Platelets; Child; Child, Preschool; Deamino Arginine Vasopressin; Female; Hemostasis; Hemostatics; Humans; Infusions, Intravenous; Male; Platelet Aggregation; Platelet Function Tests; Thrombin; von Willebrand Factor | 2011 |
Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Tests; Deamino Arginine Vasopressin; Female; Hemostasis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y; Reproducibility of Results; Sensitivity and Specificity; von Willebrand Diseases; von Willebrand Factor | 2012 |
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin.
Topics: Adenosine Diphosphate; Adult; Aptamers, Nucleotide; Blood Platelets; Cells, Cultured; Collagen; Deamino Arginine Vasopressin; Female; Humans; Lipopolysaccharides; Male; Middle Aged; Platelet Aggregation; von Willebrand Factor | 2020 |
Treatment Algorithm for Patients With von Willebrand Syndrome Type 2A and Congenital Heart Disease-A Treatment Algorithm May Reduce Perioperative Blood Loss in Children With Congenital Heart Disease.
Topics: Adenosine Diphosphate; Algorithms; Blood Loss, Surgical; Child; Deamino Arginine Vasopressin; Epinephrine; Heart Defects, Congenital; Humans; Retrospective Studies; Syndrome; von Willebrand Diseases; von Willebrand Factor | 2022 |